...
首页> 外文期刊>Cancer Cell >Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia.
【24h】

Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia.

机译:Cbf beta-SMMHC诱导能够发展为急性髓性白血病的独特的异常髓样祖细胞。

获取原文
获取原文并翻译 | 示例
           

摘要

The acute myeloid leukemia (AML)-associated CBF beta-SMMHC fusion protein impairs hematopoietic differentiation and predisposes to leukemic transformation. The mechanism of leukemia progression, however, is poorly understood. In this study, we report a conditional Cbfb-MYH11 knockin mouse model that develops AML with a median latency of 5 months. Cbf beta-SMMHC expression reduced the multilineage repopulation capacity of hematopoietic stem cells (HSCs) while maintaining their numbers under competitive conditions. The fusion protein induced abnormal myeloid progenitors (AMPs) with limited proliferative potential but leukemic predisposition similar to that of HSCs in transplanted mice. In addition, Cbf beta-SMMHC blocked megakaryocytic maturation at the CFU-Meg to megakaryocyte transition. These data show that a leukemia oncoprotein can inhibit differentiation and proliferation while not affecting the maintenance of long-term HSCs.
机译:急性髓细胞性白血病(AML)相关的CBFβ-SMMHC融合蛋白损害造血细胞分化,并易于发生白血病转化。然而,对白血病进展的机制了解甚少。在这项研究中,我们报告了条件性Cbfb-MYH11敲入小鼠模型,其发展为AML,中位潜伏期为5个月。 Cbf beta-SMMHC表达降低了造血干细胞(HSC)的多谱系再繁殖能力,同时在竞争条件下保持了它们的数量。融合蛋白诱导了异常的骨髓祖细胞(AMPs),其增殖潜能有限,但白血病的易感性类似于移植小鼠中的HSC。另外,Cbf beta-SMMHC阻止了CFU-Meg巨核细胞向巨核细胞过渡的成熟。这些数据表明,白血病癌蛋白可以抑制分化和增殖,而不会影响长期HSC的维持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号